Clinical Trial Update: A Causative Role for Amylin in Diabetic Peripheral Neuropathy

View source ↗

Summary

A clinical trial is exploring whether amylin has a causative role in diabetic peripheral neuropathy. The study is currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Zabeen Mahuwala, MD | Conditions: Type2 Diabetes, Peripheral Neuropathy | Status: RECRUITING